Apyx Medical Corp $ 6.55 0 (0%)
Volume:
0
Avg Vol (1m):
88,323
Market Cap $:
222.19 Mil
Enterprise Value $:
155.23 Mil
P/E (TTM):
0.00
P/B:
2.71
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| Peter Lynch Value | ||
|
Price: $6.55 | ||
Manual of Stocks™ Web
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 165.5 | ||
| Equity-to-Asset | 0.91 | ||
| Debt-to-Equity | 0.01 | ||
| Debt-to-EBITDA | -0.03 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 18.06 | ||
| Beneish M-Score | 2.28 | ||
| WACC vs ROIC | |||
Profitability | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -76.74 | ||
| Net Margin % | 255.57 | ||
| ROE % | 76.93 | ||
| ROA % | 66.91 | ||
| ROC (Joel Greenblatt) % | -155.06 | ||
| 3-Year Revenue Growth Rate | -23 | ||
| 3-Year EBITDA Growth Rate | -17.7 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 4.11 | ||
| Price-to-Owner-Earnings | 5.95 | ||
| PB Ratio | 2.71 | ||
| PS Ratio | 10.18 | ||
| EV-to-EBIT | -9.37 | ||
| EV-to-EBITDA | -9.74 | ||
| EV-to-Revenue | 7.08 | ||
| Current Ratio | 10.38 | ||
| Quick Ratio | 9.57 | ||
| Days Inventory | 289.74 | ||
| Days Sales Outstanding | 103.21 | ||
| Days Payable | 77.26 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.1 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 2.72 | ||
| Price-to-Median-PS-Value | 3.97 | ||
| Price-to-Peter-Lynch-Fair-Value | 43.67 | ||
| Earnings Yield (Greenblatt) % | -10.7 | ||
| Forward Rate of Return (Yacktman) % | 14.24 |